Educating Missouri Patients About Preemptive Living Donor Transplantation

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

370 participants

Study Classification

INTERVENTIONAL

Study Start Date

2008-09-30

Study Completion Date

2011-08-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This study is a group-randomized controlled trial to explore whether improved community transplant education for renal patients not yet on dialysis could increase patients' willingness to pursue preemptive living donor transplant (PLDT) and PLDT rates.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

A Randomized Trial to Reduce the Disparity in Live Donor Kidney Transplantation

NCT00785265

Chronic Kidney Disease End-stage Renal Disease

COMPLETED NA

Expanding Live Donor Kidney Transplantation Through Advocacy Training and Social Media

NCT03099434

Kidney Failure Kidney Diseases

ACTIVE_NOT_RECRUITING NA

Enhancing Education Regarding Living Donor Transplant Among Kidney Transplant Candidates

NCT01261910

Kidney Transplant Living-Donor Kidney Transplant Chronic Kidney Disease +1 more

COMPLETED NA

Reducing Disparities in Living Donor Transplant Among African Americans

NCT03819686

Kidney Transplant

COMPLETED NA

Explore Transplant at Home: Improving Low-Income ESRD Patients' Transplant Knowledge

NCT02268682

End Stage Renal Disease

COMPLETED NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Preemptive living donor transplant (PLDT), where renal patients get a living donor transplant before their kidneys fail, has better graft survival and lower mortality rates than living donor transplant following dialysis. However, not all renal patients and their living donors know about or consider living donation before a patient starts dialysis; To date, patients and donors presenting for PLDT are more likely to be Caucasian, of higher socioeconomic status, and more knowledgeable about transplant. To reach all patients newly diagnosed with kidney disease, the Missouri Kidney Program conducts a community Patient Education Program (PEP) outlining patients' transplant and dialysis options. Since 1994, approximately 2000 Missouri patients newly diagnosed with kidney disease and their family members have attended 2-day PEP classes. However, the current PEP transplant module does not significantly increase patients' willingness to pursue PLDT. Through a previous HRSA grant, Dr. Waterman designed the "Explore Transplant" education program based on Prochaska's Transtheoretical Model of Behavioral Change and her previous research to address key gaps in patients' living donation knowledge and to motivate patients to consider living donation. If funded, this study would conduct a group-randomized controlled trial to explore whether improved community transplant education for renal patients not yet on dialysis could increase patients' willingness to pursue PLDT and PLDT rates. Secondary objectives of the study are: (2) to increase rural and minority patients' access to transplant education, and (3) to describe racial, social, economic, and other influences affecting patients' PLDT willingness. The study design is a group-randomized controlled trial of 300 patients in 30 PEP classes in St. Louis, Springfield, and Kansas City, MO; patients and their family members in 15 classes will be randomized to receive the "Explore Transplant" education module, while 15 control classes will receive the traditional PEP transplant education. Across the education and control PEP classes we will compare: (1) increased willingness to pursue PLDT using baseline and follow-up attitudinal patient surveys, and (2) rates of living donation by tracking whether patients and their living donors present to any Missouri transplant center. At the conclusion of the study, we will have learned important information about how to reach and educate patients who have not yet begun dialysis and have developed a PLDT program that could be utilized in physicians' offices and by other organizations serving renal patients to increase living donation rates.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Chronic Kidney Disease End Stage Renal Disease

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

SUPPORTIVE_CARE

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Standard transplant education

Missouri Kidney Program's standard Patient Education Program (PEP) transplant module.

Group Type NO_INTERVENTION

No interventions assigned to this group

Transplant education with video

Explore Transplant transplant module featuring video

Group Type EXPERIMENTAL

Transplant education with video

Intervention Type BEHAVIORAL

1 hour standard transplant module is replaced with the Explore Transplant presentation and 20 minute video featuring transplant patients and donors

Transplant education with speakers

Explore Transplant transplant module featuring live guest speakers.

Group Type EXPERIMENTAL

Transplant education with speakers

Intervention Type BEHAVIORAL

1 hour standard transplant module is replaced with the Explore Transplant presentation and 3 live speakers: 1 deceased donor recipient, 1 living donor recipient and 1 living donor

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Transplant education with video

1 hour standard transplant module is replaced with the Explore Transplant presentation and 20 minute video featuring transplant patients and donors

Intervention Type BEHAVIORAL

Transplant education with speakers

1 hour standard transplant module is replaced with the Explore Transplant presentation and 3 live speakers: 1 deceased donor recipient, 1 living donor recipient and 1 living donor

Intervention Type BEHAVIORAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Chronic kidney disease
* Attend all 6 education modules
* 18+ years of age
* Have given consent by signing informed consent
* Speak and understand English
* Can read and understand questionnaires

Exclusion Criteria

* Patients who do not speak and understand English (material is presented orally)
* Patients who cannot read and understand the questionnaires
* Patients who are 17 years of age or younger

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes